Your browser doesn't support javascript.
loading
HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action.
Imai, Yoichi; Hirano, Mitsuhito; Kobayashi, Masayuki; Futami, Muneyoshi; Tojo, Arinobu.
Afiliación
  • Imai Y; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. imaiyo-tky@umin.ac.jp.
  • Hirano M; Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. m-hirano@ims.u-tokyo.ac.jp.
  • Kobayashi M; Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. masa-k@ims.u-tokyo.ac.jp.
  • Futami M; Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. m-futami@umin.ac.jp.
  • Tojo A; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. a-tojo@ims.u-tokyo.ac.jp.
Cancers (Basel) ; 11(4)2019 Apr 04.
Article en En | MEDLINE | ID: mdl-30987296
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Japón